Minnesota SF 3970: Pathway 2 of the safe importation action plan incentives for prescription drug manufacturers authorization

Status: Second reading (as of 2020-05-12)

State: Minnesota · Session: 2019-2020 · Bill: SF 3970

Subjects: Commerce and Commerce Department, Drugs and Medicine, Health and Health Department, Human Services and Human Services Department

Sponsors: Benson, Draheim

View Minnesota SF 3970 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.